Scilex stockholders approve repricing of stock options from $282.80 to $16.80 per share

Scilex Holding Co

Stockholders approved repricing of up to 289,405 options held by employees, executives, and board members.
Exercise price reduced from $282.80 to $16.80 (closing price on Dec 11, 2025).
CEO Henry Ji and CFO Stephen Ma among eligible participants; all other terms unchanged.
Vote: 3,341,659 for, 1,130,308 against, 23,971 abstain, no broker non-votes.
Repricing effective Dec 11, 2025; previously approved by Board on Oct 27, 2025.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.